Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Hsiaoyin Mao"'
Autor:
Qi-En Wang, Jianhua Yu, Weiqiang Zhao, Meihua Qu, Hsiaoyin Mao, Li Gong, Amit Srivastava, Xingluo Liu, Ran Zhao, Chunhua Han
PDF - 899K, Supplementary Materials and Methods; S1. Manipulation of DDB2 expression does not change EMT of ovarian cancer cells. S2. DDB2 reduces the abundance of ALDH+ cells in ovarian cancer cell lines. S3. Effect of DDB2 on the ALDH1A1 protein ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e2ebc0fb087e2b35b67ae9ec327eb00
https://doi.org/10.1158/1541-7786.22511095.v1
https://doi.org/10.1158/1541-7786.22511095.v1
Autor:
Jianying Zhang, Steven M. Devine, Hsiaoyin Mao, Liguang Chen, Jianhua Yu, Michael A. Caligiuri, Jianhong Chu
Publikováno v:
Leukemia
Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
Autor:
Amy Haseley Thorne, Luke Russell, Justin D. Lathia, Chelsea Bolyard, Ji Young Yoo, Jianhua Yu, Walter Hans Meisen, Jeremy N. Rich, Balveen Kaur, Hsiaoyin Mao, Vinay K. Puduvalli, Michael A. Caligiuri, Susheela Tridandapani
Publikováno v:
Molecular Therapy. 22:1678-1687
Glioblastoma is a devastating disease, and there is an urgent need to develop novel therapies, such as oncolytic HSV1 (OV) to effectively target tumor cells. OV therapy depends on tumor-specific replication leading to destruction of neoplastic tissue
Autor:
Hsiaoyin Mao, Weiqiang Zhao, Amit Kumar Srivastava, Li Gong, Xingluo Liu, Ran Zhao, Qi-En Wang, Jianhua Yu, Chunhua Han, Meihua Qu
Publikováno v:
Molecular Cancer Research. 12:784-794
Ovarian cancer is an extremely aggressive disease associated with a high percentage of tumor recurrence and chemotherapy resistance. Understanding the underlying mechanism of tumor relapse is crucial for effective therapy of ovarian cancer. DNA damag
Autor:
Saritha Kartan, Karen Young, David Kline, Dean A. Lee, Susan Huang, Gerard Lozanski, Hsiaoyin Mao, Aharon G. Freud, Eric McLaughlin, Basem William, Youssef Youssef, Nathan Denlinger, Rebecca Kohnken, Michael A. Caligiuri, Pierluigi Porcu, Bethany L. Mundy-Bosse, Anjali Mishra, Nitin Chakravarti, Li Chen
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S287-S288
Cutaneous T-cell lymphoma (CTCL) is characterized by the expansion of malignant CD4+ T cells in the skin. There are two main subtypes of CTCL, mycosis fungoides (MF) and Sezary syndrome (SS). Previous studies have demonstrated defects in cell-mediate
Autor:
Kalpana Ghoshal, Michael A. Caligiuri, Ling Yi, Xiaoming He, Craig C. Hofmeister, Jianying Zhang, Don M. Benson, Jianhong Chu, Yong Peng, Hsiaoyin Mao, Tiffany Hughes, Shun He, Xiaoliu Zhang, Youcai Deng, Steven M. Devine, Jianhua Yu
Publikováno v:
Leukemia
Multiple myeloma (MM) is an incurable hematological malignancy. Chimeric antigen receptor (CAR)-expressing T cells have been demonstrated successfully in the clinic to treat B-lymphoid malignancies. However, the potential utility of antigen-specific
Autor:
Shujun Liu, Il-Kyoo Park, Guido Marcucci, Hsiaoyin Mao, Rossana Trotta, Christine Hwang, Jianhua Yu, Michael A. Caligiuri, Min Wei, Jianying Zhang, Takeki Mitsui, Don M. Benson, Tiffany Hughes
Publikováno v:
The Journal of Immunology. 183:4968-4974
Understanding of heterogeneous NK subsets is important for the study of NK cell biology and development, and for the application of NK cell-based therapies in the treatment of disease. Here we demonstrate that the surface expression of CD94 can disti
Autor:
Ramasamy Santhanam, Aalok Modi, Jeffrey Allard, Rossana Trotta, Brian Becknell, Jianhua Yu, Jessica Dal Col, David Ciarlariello, Bradley W. Blaser, Hsiaoyin Mao, Amy K. Ferketich, Paolo Neviani, Danilo Perrotti, Michael A. Caligiuri, Brittany Thomas
Publikováno v:
The Journal of Experimental Medicine
Monokines (i.e., interleukin [IL]-12, -18, and -15) induce natural killer (NK) cells to produce interferon-gamma (IFN-gamma), which is a critical factor for immune surveillance of cancer and monocyte clearance of infection. We show that SET, which is
Autor:
Hsiaoyin Mao, Mario Notari, Ashwin Uttam, Rebecca Bruner-Klisovic, Shujun Liu, Clara D. Bloomfield, Mauro Valtieri, Michael A. Caligiuri, Danilo Perrotti, Rossana Trotta, Ji Suk Chang, Denis C. Roy, Ramasamy Santhanam, Bradley W. Blaser, Paolo Neviani, Annamaria Galietta, Guido Marcucci
Publikováno v:
Cancer Cell. 8:355-368
SummaryThe oncogenic BCR/ABL kinase activity induces and maintains chronic myelogenous leukemia (CML). We show here that, in BCR/ABL-transformed cells and CML blast crisis (CML-BC) progenitors, the phosphatase activity of the tumor suppressor PP2A is
Autor:
Christopher Alvarez-Breckenridge, Sumeet Sandhu, Shunzong Yuan, Tiffany Hughes, Hsiaoyin Mao, Jianying Zhang, Jianhua Yu, Don M. Benson, Shun He, Xiaoming He, Sumithira Vasu, Yong Peng, Craig C. Hofmeister, Lai-Chu Wu, Kalpana Ghoshal, Steven M. Devine, Min Wei, Jianhong Chu, Michael A. Caligiuri
MicroRNAs (miRNAs) bind to complementary sequences of target mRNAs, resulting in translational repression or target degradation and thus gene silencing. miRNAs are abundant in circulating blood, yet it is not known whether, as a class of regulatory m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::060791673316fc15a0057e4dda180484
https://europepmc.org/articles/PMC3674667/
https://europepmc.org/articles/PMC3674667/